
Cyril B DoussonAi-biopharma · Medicinal Chemistry & Chemoinformatics
Cyril B Dousson
PhD
Ai-biopharma
About
83
Publications
3,981
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
657
Citations
Introduction
Research and development of new Antiviral candidate drugs (HBV & Coronavirus), Drug Discovery, Medicinal Chemistry, Artificial Intelligence & Chemoinformatic.
Additional affiliations
February 2018 - present
Ai-biopharma
Position
- CEO
Description
- www.ai-biopharma.com
August 2014 - January 2018
August 2003 - August 2014
Education
September 1997 - November 2000
Projects
Projects (13)
Research and development of second generation Coronavirus polymerase inhibitors with wider coverge and better efficacy and tolerability.
Develop AIB-001, a new oral liver targeted HBV Polymerase inhibitor as the Backbone component of a combination therapy for HBV Functional Cure.
Antiviral - HIV Nucleos(t)ide Reverse Transcriptase Inhibitors